Habiba-Allah Ismail
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Habiba-Allah Ismail has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Antoine Fakhry AbdelMassih
Cairo University, Cairo, Egypt
5 shared publications - Meryam El Shershaby
Student and Internship research program (Research Accessibility Team), Faculty of Medicine, Cairo University, Cairo, Egypt
4 shared publications - Nadine El-Husseiny
Faculty of Dentistry, Cairo University, Cairo, Egypt
4 shared publications - Rafeef Hozaien
Student and Internship research program (Research Accessibility Team), Faculty of Medicine, Cairo University, Cairo, Egypt
4 shared publications - Aya Kamel
Student and Internship research program (Research Accessibility Team), Faculty of Medicine, Cairo University, Cairo, Egypt
3 shared publications - Raghda Fouda
University of California, Irvine, Orange, California, United States
3 shared publications
Latest Publications
- Open Access
- 11 September 2025
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 73 (1) , 1-7
Post rabies vaccination immune dysregulation; Atypical hemolytic uremic syndrome, a case report
Background: Hemolytic uremic syndrome (HUS) is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. Atypical HUS (aHUS), which is non-Shiga toxin-associated, accounts for approximately 5 to 10% of pediatric HUS cases and is associated with significant morbidity and mortality—up to 25% mortality and 48% morbidity—since many children progress to end-stage renal disease. The condition is often caused by genetic mutations affecting complement regulation, with pathogenic variants in complement genes presenting 50 to 60% of cases, or by autoantibodies against complement factor H. We report the first aHUS case, confirmed by whole exome sequencing, following two injections of purified Vero cell culture rabies vaccine (PCEC). The patient was effectively managed using a combination of plasma exchange and immunosuppressive therapy. Case presentation: A previously healthy 10-year-old boy presented with clinical features of hemolysis, elevated renal function markers, and thrombocytopenia. He had no prior history of blood transfusions, bleeding episodes, nor relevant family medical history. The only notable antecedent event was a dog bite, followed by two doses of rabies vaccination with the purified Vero cell culture vaccine. Treatment was initiated with Methylprednisolone at 30 mg/kg/day, followed by introduction of mycophenolate mofetil. Laboratory improvements were observed, yet clinical recovery was only achieved after 11 sessions of plasma exchange, highlighting the importance of early and aggressive intervention. Conclusions: This case emphasizes a potential link between rabies vaccination and the development of aHUS in genetically predisposed individuals. It also underscores the critical role of prompt plasma exchange in achieving clinical remission in such cases. Further studies are needed to explore the underlying mechanisms and confirm this association. Graphical Graphical abstract summarizing the suggested pathogenesis of the case. Abbreviations: CFH: Complement Factor H, RBCs: Red blood Cells
- 11 September 2025
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 73 (1) , 1-7
Open AccessPost rabies vaccination immune dysregulation; Atypical hemolytic uremic syndrome, a case report
Background: Hemolytic uremic syndrome (HUS) is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. Atypical HUS (aHUS), which is non-Shiga toxin-associated, accounts for approximately 5 to 10% of pediatric HUS cases and is associated with significant morbidity and mortality—up to 25% mortality and 48% morbidity—since many children progress to end-stage renal disease. The condition is often caused by genetic mutations affecting complement regulation, with pathogenic variants in complement genes presenting 50 to 60% of cases, or by autoantibodies against complement factor H. We report the first aHUS case, confirmed by whole exome sequencing, following two injections of purified Vero cell culture rabies vaccine (PCEC). The patient was effectively managed using a combination of plasma exchange and immunosuppressive therapy. Case presentation: A previously healthy 10-year-old boy presented with clinical features of hemolysis, elevated renal function markers, and thrombocytopenia. He had no prior history of blood transfusions, bleeding episodes, nor relevant family medical history. The only notable antecedent event was a dog bite, followed by two doses of rabies vaccination with the purified Vero cell culture vaccine. Treatment was initiated with Methylprednisolone at 30 mg/kg/day, followed by introduction of mycophenolate mofetil. Laboratory improvements were observed, yet clinical recovery was only achieved after 11 sessions of plasma exchange, highlighting the importance of early and aggressive intervention. Conclusions: This case emphasizes a potential link between rabies vaccination and the development of aHUS in genetically predisposed individuals. It also underscores the critical role of prompt plasma exchange in achieving clinical remission in such cases. Further studies are needed to explore the underlying mechanisms and confirm this association. Graphical Graphical abstract summarizing the suggested pathogenesis of the case. Abbreviations: CFH: Complement Factor H, RBCs: Red blood Cells
- Open Access
- 23 May 2025
- Published by MDPI AG in Preprints.org
Post Rabies Vaccination Immune Dysregulation; Atypical Hemolytic Uremic Syndrome, A Case Report
Hemolytic uremic syndrome (HUS) is characterized by the triad of mechanical micro-angiopathic hemolytic anemia, thrombocytopenia and renal impairment. Atypical Hemolytic Uremic Syndrome (aHUS); non Shiga-toxin-HUS, represents 5 -10% of HUS in children and is associated with a mortality rate of 20–25% and a morbidity of 48%, since pediatric patients typically progress to end stage renal disease (ESRD)1 It’s either caused by inherited pathogenic variants in complement gene variants, which account for 50% to 60% or by autoantibodies directed against complement factor H We report the first aHUS case, confirmed by Whole Exome Sequencing (WES), following two injections of purified Vero cell culture rabies vaccine (PCEC), which was satisfactorily managed using a combination of plasma exchange (PEX) and immunosuppressive therapy. Our case highlights the possible association between aHUS and rabies vaccination in genetically susceptible individuals.
- 23 May 2025
- Published by MDPI AG in Preprints.org
Open AccessPost Rabies Vaccination Immune Dysregulation; Atypical Hemolytic Uremic Syndrome, A Case Report
Hemolytic uremic syndrome (HUS) is characterized by the triad of mechanical micro-angiopathic hemolytic anemia, thrombocytopenia and renal impairment. Atypical Hemolytic Uremic Syndrome (aHUS); non Shiga-toxin-HUS, represents 5 -10% of HUS in children and is associated with a mortality rate of 20–25% and a morbidity of 48%, since pediatric patients typically progress to end stage renal disease (ESRD)1 It’s either caused by inherited pathogenic variants in complement gene variants, which account for 50% to 60% or by autoantibodies directed against complement factor H We report the first aHUS case, confirmed by Whole Exome Sequencing (WES), following two injections of purified Vero cell culture rabies vaccine (PCEC), which was satisfactorily managed using a combination of plasma exchange (PEX) and immunosuppressive therapy. Our case highlights the possible association between aHUS and rabies vaccination in genetically susceptible individuals.
- Open Access
- 4 April 2022
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 70 (1) , 1-9
Learned lesson from COVID-19: can routine immunizations be the first line of defense against the next pandemic?
Background: Single-cell sequencing studies on the lung microenvironment have revealed that the outcome of COVID-19 depends largely on the immune system response rather than the viral load. A robust innate immune response and a regulated adaptive immunity can prevent the worst outcomes such as hospitalization and the need for mechanical ventilation. Main body: Intriguingly, several vaccines pertaining to the routine vaccination schedule, not only BCG, can skew the immune response towards the aforementioned beneficial effects. Short conclusion: This means that routine immunization not only can help in the current pandemic but can also offer a rapid rescue in the subsequent epidemics or pandemics until a vaccine is developed.
- 4 April 2022
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 70 (1) , 1-9
Open AccessLearned lesson from COVID-19: can routine immunizations be the first line of defense against the next pandemic?
Background: Single-cell sequencing studies on the lung microenvironment have revealed that the outcome of COVID-19 depends largely on the immune system response rather than the viral load. A robust innate immune response and a regulated adaptive immunity can prevent the worst outcomes such as hospitalization and the need for mechanical ventilation. Main body: Intriguingly, several vaccines pertaining to the routine vaccination schedule, not only BCG, can skew the immune response towards the aforementioned beneficial effects. Short conclusion: This means that routine immunization not only can help in the current pandemic but can also offer a rapid rescue in the subsequent epidemics or pandemics until a vaccine is developed.
- Open Access
- 2 December 2021
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 69 (1) , 1-8
Should we vaccinate the better seroconverters or the most vulnerable? Game changing insights for COVID-19 vaccine prioritization policies
Background: With the rapid rise in COVID 19 cases incomparable to the number of vaccinations available, there has been a demand to prioritize the older age groups receiving the vaccine as they have more risk of morbidity and mortality and thus better outcome from vaccination. Main body: Some studies showed a lower seroconversion rate in older group patients; thus, we discuss the necessity to reprioritize vaccinations to younger age groups who have better seroconversion rates, but we may face some ethical dilemma that could hinder our hypothesis. Decreased seroconversion rates in adults are attributable to immuno-senescence which involves a decrease in humoral and cellular-mediated immunity with age. Despite this fact, there remains some ethical dilemma that can hinder widespread vaccination of younger generations, the most important of which is the unknown long-term effects of COVID-19 vaccines due their fast-tracking under the pressure of the pandemic. Short conclusion: Prioritizing children vaccination against COVID-19 seems an interesting strategy that can help in containing the pandemic. Resolving some ethical dilemma needs to be done before implementing such strategy.
- 2 December 2021
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 69 (1) , 1-8
Open AccessShould we vaccinate the better seroconverters or the most vulnerable? Game changing insights for COVID-19 vaccine prioritization policies
Background: With the rapid rise in COVID 19 cases incomparable to the number of vaccinations available, there has been a demand to prioritize the older age groups receiving the vaccine as they have more risk of morbidity and mortality and thus better outcome from vaccination. Main body: Some studies showed a lower seroconversion rate in older group patients; thus, we discuss the necessity to reprioritize vaccinations to younger age groups who have better seroconversion rates, but we may face some ethical dilemma that could hinder our hypothesis. Decreased seroconversion rates in adults are attributable to immuno-senescence which involves a decrease in humoral and cellular-mediated immunity with age. Despite this fact, there remains some ethical dilemma that can hinder widespread vaccination of younger generations, the most important of which is the unknown long-term effects of COVID-19 vaccines due their fast-tracking under the pressure of the pandemic. Short conclusion: Prioritizing children vaccination against COVID-19 seems an interesting strategy that can help in containing the pandemic. Resolving some ethical dilemma needs to be done before implementing such strategy.
- Open Access
- 22 October 2021
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 19 (1) , 165-5
The potential role of inhaled nitric oxide for postexposure chemoprophylaxis of COVID-19
- 22 October 2021
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 19 (1) , 165-5
Open AccessThe potential role of inhaled nitric oxide for postexposure chemoprophylaxis of COVID-19
- Open Access
- 12 April 2021
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 69 (1) , 1-13
COVID-19 during pregnancy should we really worry from vertical transmission or rather from fetal hypoxia and placental insufficiency? A systematic review
Background: COVID-19 is the largest outbreak to strike humanity. The wide scale of fatalities and morbidities lead to a concurrent pandemic of uncertainty in scientific evidence. Conflicting evidences are released on daily basis about the neonatal outcomes of COVID-19-positive mothers. The aim of this study was to use the relevant case reports and series to determine the percentage of newborns who test positive for COVID-19 who are born to COVID-19-positive mothers. Secondary outcomes included examining laboratory abnormalities among COVID-19-positive neonates, and any depicted placental abnormalities in COVID-19-positive mothers. For this purpose, systematic review was performed on all studies reporting primary data on fetus-mother pairs with COVID-19. Data bases were searched for studies that met our inclusion and exclusion criteria.Results: Final screening revealed 67 studies, from which the primary data of 1787 COVID-19 mothers were identified and had their pregnancy outcome analyzed. Only 2.8% of infants born to COVID-19-positive mothers tested positive, and this finding is identical to percentages reported in former Coronaviridae outbreaks, whereas 20% manifested with intrauterine hypoxia alongside placental abnormalities suggestive of heavy placental vaso-occlusive involvement.Conclusions: These findings suggest that while vertical transmission is unlikely, there appears to be an underlying risk of placental insufficiency due to the prothrombotic tendency observed in COVID-19 infection. Guidelines for proper prophylactic anticoagulation in COVID-positive mothers need to be established.
- 12 April 2021
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 69 (1) , 1-13
Open AccessCOVID-19 during pregnancy should we really worry from vertical transmission or rather from fetal hypoxia and placental insufficiency? A systematic review
Background: COVID-19 is the largest outbreak to strike humanity. The wide scale of fatalities and morbidities lead to a concurrent pandemic of uncertainty in scientific evidence. Conflicting evidences are released on daily basis about the neonatal outcomes of COVID-19-positive mothers. The aim of this study was to use the relevant case reports and series to determine the percentage of newborns who test positive for COVID-19 who are born to COVID-19-positive mothers. Secondary outcomes included examining laboratory abnormalities among COVID-19-positive neonates, and any depicted placental abnormalities in COVID-19-positive mothers. For this purpose, systematic review was performed on all studies reporting primary data on fetus-mother pairs with COVID-19. Data bases were searched for studies that met our inclusion and exclusion criteria.Results: Final screening revealed 67 studies, from which the primary data of 1787 COVID-19 mothers were identified and had their pregnancy outcome analyzed. Only 2.8% of infants born to COVID-19-positive mothers tested positive, and this finding is identical to percentages reported in former Coronaviridae outbreaks, whereas 20% manifested with intrauterine hypoxia alongside placental abnormalities suggestive of heavy placental vaso-occlusive involvement.Conclusions: These findings suggest that while vertical transmission is unlikely, there appears to be an underlying risk of placental insufficiency due to the prothrombotic tendency observed in COVID-19 infection. Guidelines for proper prophylactic anticoagulation in COVID-positive mothers need to be established.
- Open Access
- 1 July 2020
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 68 (1) , 1-7
Unleashing the mysterious link between COVID-19 and a famous childhood vasculitis: Kawasaki disease
Background: Coronavirus disease 2019 (COVID-19) emerged as a small outbreak in Wuhan rapidly progressing into the deadliest pandemic since the Spanish flu of 1918. The disease was deemed trivial in children, until the reporting, few days ago, of an emerging pediatric multi-inflammatory syndrome mimicking Kawasaki disease (KD). Main body: This report reveals that coronaviridae were implicated in induction of several post-infectious vasculitides, namely, KD, AHEI, and HSP. This occurs in genetically susceptible individuals to vascular inflammation. Shared genetic susceptibilities between KD and CoV include genes encoding for CD 40, HLAB-15:03, and ACE. This leads to augmented inflammation with hypersecretion of cytokines especially IL-6. Conclusion: The revealed relationships between KD and CoV can help to predict the risk of KD in COVID-19 patients through screening levels of upregulated cytokines. It might also signify that classic treatment of KD with IVIG might need to be replaced with anti-cytokine therapy in COVID-19 patients.
- 1 July 2020
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 68 (1) , 1-7
Open AccessUnleashing the mysterious link between COVID-19 and a famous childhood vasculitis: Kawasaki disease
Background: Coronavirus disease 2019 (COVID-19) emerged as a small outbreak in Wuhan rapidly progressing into the deadliest pandemic since the Spanish flu of 1918. The disease was deemed trivial in children, until the reporting, few days ago, of an emerging pediatric multi-inflammatory syndrome mimicking Kawasaki disease (KD). Main body: This report reveals that coronaviridae were implicated in induction of several post-infectious vasculitides, namely, KD, AHEI, and HSP. This occurs in genetically susceptible individuals to vascular inflammation. Shared genetic susceptibilities between KD and CoV include genes encoding for CD 40, HLAB-15:03, and ACE. This leads to augmented inflammation with hypersecretion of cytokines especially IL-6. Conclusion: The revealed relationships between KD and CoV can help to predict the risk of KD in COVID-19 patients through screening levels of upregulated cytokines. It might also signify that classic treatment of KD with IVIG might need to be replaced with anti-cytokine therapy in COVID-19 patients.